Dr. Anup Hegde specializes in the diagnosis and treatment of solid tumors and hematological cancers, including breast, lung, gastrointestinal, head and neck cancers, lymphoma, and leukemia. His expertise spans chemotherapy, immunotherapy, targeted therapy, and bone marrow transplantation. With dual training in Medical Oncology and Radiation Oncology, he brings a comprehensive, multidisciplinary approach to managing both common and complex cancers with precision and compassion.

Dr. Hegde’s strength lies in his evidence-based, guideline-driven, and multidisciplinary treatment philosophy. He combines scientific rigor with compassionate care, ensuring patients receive personalized treatment plans tailored to cancer type, stage, and individual needs. His dual specialization offers a unique perspective on integrating medical and radiation oncology, helping optimize outcomes. He also emphasizes transparency, detailed communication, and timely interventions, making the cancer journey more informed, structured, and supportive.

Dr. Hegde is proficient in key oncologic procedures including bone marrow aspiration, biopsy, intrathecal chemotherapy, chemoport insertion, PICC line placement, and central venous access. These procedures help ensure safe and seamless delivery of cancer treatments. His expertise in advanced techniques reduces patient discomfort, minimizes complications, and supports a smooth treatment experience, especially during chemotherapy or bone marrow transplantation.

He offers a full spectrum of advanced treatments including chemotherapy, immunotherapy, hormonal therapy, targeted therapy, and bone marrow transplantation. Dr. Hegde also integrates personalized approaches like genomic-based treatment selection, precision oncology, and multidisciplinary tumor board discussions. His focus is to provide the most effective, latest evidence-backed therapies while maintaining quality of life and managing side effects proactively throughout the treatment journey.

Dr. Hegde has over eight years of clinical experience and has completed rigorous DM training at the prestigious Kidwai Memorial Institute of Oncology. He holds dual specializations in Medical and Radiation Oncology, enhancing his understanding of multimodal cancer care. His global certifications, including clearing the ESMO exam and MRCP (UK) SCE, reflect international standards of expertise. His academic achievements include national awards, research publications, and conference presentations.

Yes. As an Associate Consultant at Fortis Hospital, Bangalore, Dr. Hegde plays an active role in multidisciplinary tumor boards. He collaborates with surgeons, radiation oncologists, pathologists, and radiologists to develop personalized, evidence-backed treatment plans. These discussions ensure that every case is reviewed from multiple expert perspectives, improving accuracy in diagnosis, staging, and treatment decisions tailored specifically to each patient.

Patients with newly diagnosed cancers, recurrent disease, advanced-stage malignancies, or those seeking second opinions benefit greatly from his expertise. He offers specialized care for solid tumors, blood cancers, and conditions requiring complex therapies like immunotherapy or bone marrow transplantation. Individuals looking for precision oncology, genetic testing-based treatment, or a structured, transparent treatment journey also find his approach highly beneficial.

Yes. Dr. Hegde provides detailed second opinions for difficult, rare, or advanced cancers. His guideline-based approach ensures clarity on diagnosis, staging, and treatment options. He reviews previous reports, imaging, and biopsy findings to recommend the most effective treatment pathway. Patients seeking confirmation, alternate approaches, or access to advanced therapies such as immunotherapy and targeted treatments can rely on his expertise.

Dr. Hegde emphasizes holistic, patient-centered care and offers pain management, palliative care, symptom control, and psychosocial support. He ensures that patients receive continuous guidance throughout the treatment process, addressing side effects, nutrition, emotional wellbeing, and long-term survivorship planning. His goal is to help patients maintain comfort, dignity, and quality of life while undergoing cancer treatment

He uses precision oncology tools such as genetic testing, molecular profiling, and biomarker analysis to tailor treatments to the cancer’s unique biology. This helps identify targeted therapies and immunotherapies that are more effective and less toxic. Precision-based decisions improve outcomes, reduce unnecessary treatments, and offer access to the most advanced therapeutic options available today.